News
This early analysis suggests that the combination of oral decitabine plus cedazuridine with venetoclax for higher-risk-myelodysplastic syndromes and chronic myelomonocytic leukaemia is safe in most ...
Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to ...
New research from Smoke Free Sweden reveals oral nicotine pouches are a game-changer in Sweden’s path to becoming the world’s first smoke-free nation – and a ...
Labuz-Roszak B et al. Multiple Sclerosis: Oral Health, Behaviours and Limitations of Daily Oral Hygiene — a Questionnaire Study. Neurologia i Neurochirurgia Polska . August 23, 2019.
A University of Chicago spinout has raised $4 million in seed funding to develop a unique, saliva-based test for oral cancers. OrisDX's funding was led by Revere Partners and strategic investment ...
MDM2 is a key negative regulator of the tumor suppressor p53 and an attractive target for cancer therapy. We report the discovery of MD-4251, the first orally efficacious MDM2 degrader developed using ...
This skincare solution has garnered an impressive 4.62-star rating based on over 1,000 reviews. One customer commented: "The Neutralising Gel is my favorite, as a lot of spot treatments tend to be ...
With a 4.62-star rating based on over 1,000 reviews, the Flawless Neutralising Gel has become a favourite among customers. One reviewer said: "The Neutralising Gel is my favourite, as a lot of ...
Sun Pharmaceutical Industries has halted the development of its oral drug SCD-044 after it failed to meet primary efficacy endpoints in Phase 2 trials for psoriasis and atopic dermatitis. Sun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results